Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) EBITDA Margin (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of EBITDA Margin readings, the most recent being 0.95% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 2505.0% to 0.95% in Q4 2025 year-over-year; TTM through Dec 2025 was 27.68%, a 1310.0% increase, with the full-year FY2025 number at 27.57%, up 1290.0% from a year prior.
  • EBITDA Margin hit 0.95% in Q4 2025 for SBC Medical Group Holdings, down from 13.91% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 66.21% in Q1 2025 to a low of 26.01% in Q4 2024.
  • Median EBITDA Margin over the past 3 years was 16.76% (2024), compared with a mean of 20.64%.
  • Biggest five-year swings in EBITDA Margin: plummeted -6153bps in 2024 and later skyrocketed 5060bps in 2025.
  • SBC Medical Group Holdings' EBITDA Margin stood at 35.52% in 2023, then crashed by -173bps to 26.01% in 2024, then surged by 96bps to 0.95% in 2025.
  • The last three reported values for EBITDA Margin were 0.95% (Q4 2025), 13.91% (Q3 2025), and 25.52% (Q2 2025) per Business Quant data.